ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 158 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.09 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,445,000 | +92.4% | 38,350 | +42.4% | 0.01% | +100.0% |
| Q2 2017 | $751,000 | +77.1% | 26,940 | +118.3% | 0.00% | +50.0% |
| Q1 2017 | $424,000 | -63.3% | 12,340 | -66.0% | 0.00% | -60.0% |
| Q3 2016 | $1,156,000 | +30.3% | 36,330 | +33.0% | 0.01% | +25.0% |
| Q2 2016 | $887,000 | -42.7% | 27,320 | -49.9% | 0.00% | -42.9% |
| Q1 2016 | $1,548,000 | -34.8% | 54,547 | -18.2% | 0.01% | -30.0% |
| Q4 2015 | $2,376,000 | +39.8% | 66,643 | +29.8% | 0.01% | +25.0% |
| Q3 2015 | $1,699,000 | -21.5% | 51,361 | -0.5% | 0.01% | -11.1% |
| Q2 2015 | $2,163,000 | -45.8% | 51,642 | -57.9% | 0.01% | -43.8% |
| Q1 2015 | $3,994,000 | +110.1% | 122,558 | +104.6% | 0.02% | +100.0% |
| Q4 2014 | $1,901,000 | +26.6% | 59,889 | -1.2% | 0.01% | +33.3% |
| Q3 2014 | $1,501,000 | +9.6% | 60,635 | +0.0% | 0.01% | 0.0% |
| Q2 2014 | $1,369,000 | +1.0% | 60,621 | +11.8% | 0.01% | 0.0% |
| Q4 2013 | $1,355,000 | -11.5% | 54,212 | -2.8% | 0.01% | -14.3% |
| Q3 2013 | $1,531,000 | +274.3% | 55,745 | +147.4% | 0.01% | +250.0% |
| Q2 2013 | $409,000 | – | 22,534 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 647,833 | $26,723,000 | 11.32% |
| GREAT POINT PARTNERS LLC | 1,921,563 | $79,264,000 | 7.13% |
| Baker Brothers Advisors | 41,904,586 | $1,728,564,000 | 6.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 486,000 | $20,048,000 | 6.47% |
| Palo Alto Investors LP | 1,832,300 | $75,582,000 | 4.15% |
| Birchview Capital, LP | 204,000 | $8,416,000 | 2.81% |
| SECTORAL ASSET MANAGEMENT INC | 556,514 | $22,956,000 | 1.97% |
| Rock Springs Capital Management LP | 1,573,200 | $64,895,000 | 1.65% |
| Riggs Asset Managment Co. Inc. | 17,470 | $2,025,000 | 0.85% |
| PFM Health Sciences, LP | 421,087 | $17,370,000 | 0.80% |